
Sign up to save your podcasts
Or


In the first of a two part-series, Anthony and Bernie dive into the data surrounding maintenance therapies in AML. This episode focuses on maintenance therapy for patients ineligible for transplant, with a focus on oral azacitidine and the controversial QUAZAR study.
Key References:
By Bernard Marini, Anthony Perissinotti, et al.4.5
3030 ratings
In the first of a two part-series, Anthony and Bernie dive into the data surrounding maintenance therapies in AML. This episode focuses on maintenance therapy for patients ineligible for transplant, with a focus on oral azacitidine and the controversial QUAZAR study.
Key References:

38,482 Listeners

26,040 Listeners

88,023 Listeners

113,446 Listeners

56,951 Listeners

187 Listeners

10,331 Listeners

7,237 Listeners

53 Listeners

8 Listeners

16,543 Listeners

10,983 Listeners

51 Listeners

196 Listeners

737 Listeners